Invitrogen acquires Ethrog

IVGN acquired Ethrog Biotechnologies for 200,000 IVGN shares, or about $15.1 million, based on IVGN's $75.50 close on Wednesday. Supply/service play IVGN has marketed Ethrog's E-Gel electrophoretic ma...